A Tailor-Made Cancer Treatment Is Wowing Wall Street

It’s a cancer therapy straight out of Greek mythology, bespoke medicine with astonishing results in the smallest and sickest of patients.

The treatment, called a chimeric antigen receptor, or CAR for short, has captured the attention of the biggest drug companies and become a hotbed for biotechnology startups. A medical amalgam like the chimera in Homer’s “Iliad” -- a fire-breathing monster with a lion’s head, a goat’s body and a snake’s tail -- it may offer the best chance for patients like toddler Greta Oberhofer to beat acute lymphoblastic leukemia.